Published in J Adolesc on June 15, 2012
The impact of time perspective latent profiles on college drinking: a multidimensional approach. Subst Use Misuse (2015) 0.77
Relative importance of individual and social factors in improving adolescent health. Perspect Public Health (2013) 0.75
Clinical outcome in metastatic renal cell carcinoma patients after failure of initial vascular endothelial growth factor-targeted therapy. Urology (2010) 1.68
Analyses of second-generation 'legal highs' in the UK: initial findings. Drug Test Anal (2010) 1.61
Risk-taking but not response inhibition or delay discounting predict alcohol consumption in social drinkers. Drug Alcohol Depend (2010) 1.34
Second generation mephedrone. The confusing case of NRG-1. BMJ (2010) 1.27
The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy. J Psychopharmacol (2006) 1.19
Correlation of NRAS mutations with clinical response to high-dose IL-2 in patients with advanced melanoma. J Immunother (2012) 1.18
Multiple behavioural impulsivity tasks predict prospective alcohol involvement in adolescents. Addiction (2013) 1.17
Is ecstasy perceived to be safe? A critical survey. Drug Alcohol Depend (2005) 1.15
Ego depletion increases ad-lib alcohol consumption: investigating cognitive mediators and moderators. Exp Clin Psychopharmacol (2011) 1.07
The content of ecstasy tablets: implications for the study of their long-term effects. Addiction (2002) 1.05
A behavioural economic analysis of alcohol, amphetamine, cocaine and ecstasy purchases by polysubstance misusers. Drug Alcohol Depend (2004) 1.04
Components of behavioural impulsivity and automatic cue approach predict unique variance in hazardous drinking. Psychopharmacology (Berl) (2011) 1.02
Orthotopic xenografts of RCC retain histological, immunophenotypic and genetic features of tumours in patients. J Pathol (2011) 1.02
The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA). Neurosci Biobehav Rev (2003) 1.02
Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones. Drug Test Anal (2010) 1.02
Peer-mentoring for first-time mothers from areas of socio-economic disadvantage: a qualitative study within a randomised controlled trial. BMC Health Serv Res (2008) 0.99
Effects of alcohol preload on attentional bias towards cocaine-related cues. Psychopharmacology (Berl) (2010) 0.97
Use, function, and subjective experiences of gamma-hydroxybutyrate (GHB). Drug Alcohol Depend (2007) 0.95
Self-reported psychopathology in polydrug users. J Psychopharmacol (2004) 0.95
The effects of price and perceived quality on the behavioural economics of alcohol, amphetamine, cannabis, cocaine, and ecstasy purchases. Drug Alcohol Depend (2007) 0.94
Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis. J Psychopharmacol (2005) 0.87
Cyproheptadine resembles clozapine in vivo following both acute and chronic administration in rats. J Psychopharmacol (2007) 0.87
Olanzapine and JL13 induce cross-tolerance to the clozapine discriminative stimulus in rats. Behav Pharmacol (2007) 0.84
A comparison of the anticipated and pharmacological effects of alcohol on cognitive bias, executive function, craving and ad-lib drinking. J Psychopharmacol (2012) 0.83
Effects of 0.4 g/kg alcohol on attentional bias and alcohol-seeking behaviour in heavy and moderate social drinkers. J Psychopharmacol (2012) 0.83
Endovascular stenting for descending aneurysms: wave of the future or the emperor's new clothes? J Thorac Cardiovasc Surg (2007) 0.81
H(1)-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology (2003) 0.81
Brief report: School exclusion drug use and delinquency in adolescence. J Adolesc (2006) 0.81
Substance use behaviors of young people with a moderate learning disability: a longitudinal analysis. Am J Drug Alcohol Abuse (2007) 0.80
The effects of exercise and body armor on cognitive function in healthy volunteers. Mil Med (2013) 0.80
Frequent cannabis use among 14/15 years old in Northern Ireland. Drug Alcohol Depend (2006) 0.79
The effects of perceived quality on the behavioural economics of alcohol, amphetamine, cannabis, cocaine, and ecstasy purchases. Drug Alcohol Depend (2008) 0.79
MDMA and the "ecstasy paradigm". J Psychoactive Drugs (2014) 0.78
Can health campaigns make people ill? The iatrogenic potential of population-based cannabis prevention. J Epidemiol Community Health (2007) 0.77
Discriminative stimulus properties in rats of the novel antipsychotic quetiapine. Exp Clin Psychopharmacol (2002) 0.76
Potentiation of olanzapine substitution in rats discriminating clozapine by the D2/3 agonist quinpirole. Behav Pharmacol (2007) 0.76
Olanzapine withdrawal/discontinuation-induced hyperthermia in rats. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.76
Methodological problems with ecstasy and the SCL-90. Psychopharmacology (Berl) (2002) 0.75
Stimulus properties of the "atypical" antipsychotic zotepine in rats: comparisons with clozapine and quetiapine. Pharmacol Biochem Behav (2004) 0.75
NICE guidance on ADHD. Diversion and abuse of methylphenidate in light of new guidance. BMJ (2008) 0.75
Data openness. Don't forget preclinical science. BMJ (2010) 0.75
A profile of adolescent cocaine use in Northern Ireland. Int J Drug Policy (2008) 0.75
Measuring hypnotizability: the case for self-report depth scales and normative data for the long Stanford scale. Int J Clin Exp Hypn (2008) 0.75